Top

15-11-2024 | Demyelinating Disease | Letter to the Editor Free for a limited time

Clinical relapse after 52 years in myelin oligodendrocyte glycoprotein antibody-associated disease

Authors: Benjamin P. Trewin, Hanka Laue-Gizzi, John Downie, Ian Francis, Sudarshini Ramanathan, Todd A. Hardy

Excerpt

Dear Editor-in-Chief, …

Trewin BP, Dale RC, Qiu J et al (2024) Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse. J Neurol. https://doi.org/10.1136/jnnp-2024-333463. Neurosurg Psychiatry jnnp-2024-333463CrossRef

Gigengack NK, Oertel FC, Motamedi S et al (2022) Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders. Sci Rep 12:17545. https://doi.org/10.1038/s41598-022-19848-4CrossRefPubMedPubMedCentral

Banwell B, Bennett JL, Marignier R et al (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol 22:268–282. https://doi.org/10.1016/s1474-4422(22)00431-8CrossRefPubMed

Deschamps R, Pique J, Ayrignac X et al (2021) The long-term outcome of MOGAD: an observational national cohort study of 61 patients. Eur J Neurol 28:1659–1664. https://doi.org/10.1111/ene.14746CrossRefPubMed

Mayuzumi Y, Kitazawa Y, Kunimatsu T (2023) Relapse of myelin oligodendrocyte glycoprotein antibody-associated demyelinating disease in an elderly patient after long-term remission. Acta Neurol Belg 123:1531–1532. https://doi.org/10.1007/s13760-022-01983-4CrossRefPubMed

Havla J, Kümpfel T, Schinner R et al (2017) Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. J Neurol 264:139–151. https://doi.org/10.1007/s00415-016-8333-7CrossRefPubMed

Title: Clinical relapse after 52 years in myelin oligodendrocyte glycoprotein antibody-associated disease
Authors: Benjamin P. Trewin
Hanka Laue-Gizzi
John Downie
Ian Francis
Sudarshini Ramanathan
Todd A. Hardy
Publication date: 15-11-2024
Publisher: Springer International Publishing
Keywords: Demyelinating Disease
Optic Neuritis
Diagnostics in Neurology
Eye Examinations
Magnetic Resonance Imaging
Cranial MRI
Neurological Tests
Neurologic Therapy
Neuromyelitis Optica Spectrum Disease
Multiple Sclerosis
Published in: Neurological Sciences
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-024-07877-y

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Advances in Alzheimer's

Alzheimer's Disease
Independent Medical Education

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:

Lilly

Developed by: Springer Healthcare IME

Learn more

Keynote series | Spotlight on menopause

Springer Medicine

Excerpt

Please log in to get access to this content

Keynote series | Spotlight on menopause

Advances in Alzheimer's